These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19041190)

  • 1. Anti-estrogenic agents might be more favorable option for treatment of hereditary hemorrhagic telangiectasia.
    Zheng JW; Zhou Q; Yang XJ; Wang YA; Ye WM; Zhu HG; Zhang ZY
    Med Hypotheses; 2009 Feb; 72(2):230-1. PubMed ID: 19041190
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.
    Yaniv E; Preis M; Shevro J; Nageris B; Hadar T
    Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic effects of tamoxifen in hereditary hemorrhagic telangiectasia.
    Zacharski LR; Dunbar SD; Newsom WA
    Thromb Haemost; 2001 Feb; 85(2):371-2. PubMed ID: 11246565
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
    Yaniv E; Preis M; Hadar T; Shvero J; Haddad M
    Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptors in hereditary hemorrhagic telangiectasia.
    Richtsmeier W; Weaver G; Streck W; Jacobson H; Dewell R; Olson J
    Otolaryngol Head Neck Surg; 1984 Oct; 92(5):564-70. PubMed ID: 6438587
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid.
    Korzenik JR; Topazian MD; White R
    N Engl J Med; 1994 Nov; 331(18):1236. PubMed ID: 7935675
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal therapy for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.
    Proctor DD; Henderson KJ; Dziura JD; White RI
    J Clin Gastroenterol; 2008 Jul; 42(6):756-7. PubMed ID: 18496387
    [No Abstract]   [Full Text] [Related]  

  • 8. Worsening of nose bleeding heralds high cardiac output state in hereditary hemorrhagic telangiectasia.
    Khalid SK; Pershbacher J; Makan M; Barzilai B; Goodenberger D
    Am J Med; 2009 Aug; 122(8):779.e1-9. PubMed ID: 19635281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term therapy with thalidomide in hereditary hemorrhagic telangiectasia: case report and literature review.
    Chen CH; Hsu HH; Hu RH; Lee PH; Ho CM
    J Clin Pharmacol; 2012 Sep; 52(9):1436-40. PubMed ID: 22031620
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement in hereditary hemorrhagic telangiectasia after treatment with the phosphoinositide 3-kinase inhibitor BKM120.
    Geisthoff UW; Nguyen HL; Hess D
    Ann Hematol; 2014 Apr; 93(4):703-4. PubMed ID: 23892886
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence.
    Grainger DJ; Schofield PM
    Circulation; 2005 Nov; 112(19):3018-24. PubMed ID: 16275887
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of systemic bevacizumab in severe hereditary hemorrhagic telangiectasia associated with bleeding.
    Epperla N; Kapke JT; Karafin M; Friedman KD; Foy P
    Am J Hematol; 2016 Jun; 91(6):E313-4. PubMed ID: 26994402
    [No Abstract]   [Full Text] [Related]  

  • 13. Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better?
    Epperla N; Kleman A; Karafin M; Foy P
    Ann Hematol; 2018 Sep; 97(9):1727-1729. PubMed ID: 29656313
    [No Abstract]   [Full Text] [Related]  

  • 14. Hereditary hemorrhagic telangiectasia.
    Williams DS
    J Insur Med; 2006; 38(3):230-2. PubMed ID: 17076147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogens and pharmacological modulation of estrogen receptors].
    Sanidize TV; Ratiani LR; Gabuniia LIu; Tortladze ML; Kuridze NN
    Georgian Med News; 2009 Feb; (167):99-102. PubMed ID: 19276483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of estrogen receptors.
    Ray S; Rastogi R; Kumar A
    Prog Drug Res; 2002; 59():201-32. PubMed ID: 12458968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary hemorrhagic telangiectasia response to aminocaproic acid treatment.
    Annichino-Bizzacchi JM; Facchini RM; Torresan MZ; Arruda VR
    Thromb Res; 1999 Oct; 96(1):73-6. PubMed ID: 10554087
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of polidocanol in teleangiectasic vascular alterations in Rendu-Osler's disease.
    Palomeque JC; Ruiz HG
    Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):254. PubMed ID: 17250648
    [No Abstract]   [Full Text] [Related]  

  • 19. [An unusual presentation of liver involvement in hereditary hemorrhagic telangiectasia biliary disease].
    Casas J; Castañeda O; Prezza P; Castillo M; Llosa L
    Rev Gastroenterol Peru; 2009; 29(3):266-71. PubMed ID: 19898600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are flavonoids agonists or antagonists of the natural hormone 17beta-estradiol?
    Marino M; Galluzzo P
    IUBMB Life; 2008 Apr; 60(4):241-4. PubMed ID: 18344194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.